Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (Q29619615)

From Wikidata

Jump to navigation Jump to search

scientific article (publication date: 24 July 2010)

Language	Label	Description	Also known as
English	Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial	scientific article (publication date: 24 July 2010)

Statements

scholarly article

0 references

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial (English)

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

1 reference

based on heuristic

inferred from title

1 reference

based on heuristic

inferred from title

Rita Schmutzler

12

object named as

Schmutzler RK

1 reference

30 April 2017

Jeffrey N Weitzel

8

object named as

Weitzel JN

1 reference

30 April 2017

author name string

Audeh MW

1

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Carmichael J

2

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Penson RT

3

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Friedlander M

4

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Powell B

5

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Bell-McGuinn KM

6

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Scott C

7

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Oaknin A

9

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Loman N

10

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Lu K

11

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Matulonis U

13

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Wickens M

14

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Tutt A

15

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

language of work or name

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

publication date

24 July 2010

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

376

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

245-51

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

9737

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

The PARP superfamily

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Mutation in Brca2 stimulates error-prone homology-directed repair of DNA double-strand breaks occurring between repeated sequences

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Brca1 controls homology-directed DNA repair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA2 is required for homology-directed repair of chromosomal breaks

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The cancer connection: BRCA1 and BRCA2 tumor suppression in mice and humans.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Preventing future cancers by testing women with ovarian cancer for BRCA mutations

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

BRCA1 and BRCA2 in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of BRCA1/2 mutations on long-term survival of patients with invasive ovarian cancer: the national Israeli study of ovarian cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

A synthetic lethal therapeutic approach: poly(ADP) ribose polymerase inhibitors for the treatment of cancers deficient in DNA double-strand break repair

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Deficiency in the Repair of DNA Damage by Homologous Recombination and Sensitivity to Poly(ADP-Ribose) Polymerase Inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Exploiting the DNA Repair Defect in BRCA Mutant Cells in the Design of New Therapeutic Strategies for Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

The concept of synthetic lethality in the context of anticancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficient Deletion of NormalBrca2-Deficient Intestinal Epithelium by Poly(ADP-Ribose) Polymerase Inhibition Models Potential Prophylactic Therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

High sensitivity of BRCA1-deficient mammary tumors to the PARP inhibitor AZD2281 alone and in combination with platinum drugs

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Poly(ADP)-ribose polymerase inhibition: frequent durable responses in BRCA carrier ovarian cancer correlating with platinum-free interval

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Functional restoration of BRCA2 protein by secondary BRCA2 mutations in BRCA2-mutated ovarian carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Resistance to therapy caused by intragenic deletion in BRCA2

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Ovarian carcinomas with genetic and epigenetic BRCA1 loss have distinct molecular abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2810%2960893-8

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0140-6736(10)60893-8

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

OpenCitations bibliographic resource ID

1 reference

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

2 references

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20609468

30 April 2017

Consolidated OpenCitations Corpus – April 2017

OpenCitations bibliographic resource ID

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q29619615&oldid=2133238848"